Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011
A report of the Australian Mycobacterium Reference Laboratory Network
DOI:
https://doi.org/10.33321/cdi.2014.38.58Keywords:
Mycobacterium tuberculosis, Mycobacterium bovis, multi-drug-resistant, laboratory diagnosis, drug resistanceAbstract
The Australian Mycobacterium Reference Laboratory Network collects and analyses laboratory data on new cases of disease caused by the Mycobacterium tuberculosis complex. In 2011, a total of 1,057 cases were identified bacteriologically; an annual reporting rate of 4.6 cases per 100,000 population. Eighteen children aged less than 15 years plus an additional 11 children from the Torres Strait Protected Zone had bacteriologically-confirmed tuberculosis. Results of in vitro drug susceptibility testing were available for 1,056 isolates for isoniazid, rifampicin, ethambutol, and pyrazinamide. A total of 107 (10.0%) isolates of M. tuberculosis were resistant to at least one of these anti-tuberculosis agents. Resistance to at least isoniazid and rifampicin (defined as multi-drug resistance, MDR) was detected in 25 (2.4%) isolates; 18 were from the respiratory tract (sputum n=14, bronchoscopy n=3, tissue n=1). Ten (55.6%) of the MDR-TB-positive sputum specimens were smear-positive, as was a single sample from a lymph node. Ten patients with MDR-TB were Papua New Guinea (PNG) nationals in the Torres Strait Protected Zone. If these PNG nationals are excluded from the analysis, the underlying MDR-TB rate in Australia was 1.4%. No cases of extensively drug-resistant TB (defined as MDR-TB with additional resistance to a fluoroquinolone and an injectable agent) were detected in 2011. Commun Dis Intell 2014;38(4):E369–E375.
Downloads
References
World Health Organization. Global tuberculosis control: WHO report 2012. Geneva: World Health Organization WHO/HTM/TB/2012.6.
Barry C, Waring J, Stapledon R, and the National Tuberculosis Advisory Committee, for the Communicable Diseases Network Australia. Tuberculosis notifications in Australia, 2008 and 2009. Commun Dis Intell 2013;36(1):82–94.
Barry C, Waring J, Stapledon R, and the National Tuberculosis Advisory Committee, for the Communicable Diseases Network Australia. Tuberculosis notifications in Australia, 2010. Commun Dis Intell 2013;38(1):E36–E48.
Bareja C, Waring J, Stapledon R, Toms C, Douglas P, and the National Tuberculosis Advisory Committee for the Communicable Diseases Network Australia. Tuberculosis notifications in Australia, 2011. Commun Dis Intell 2014;38(4):E356–E368.
National Tuberculosis Advisory Committee. National strategic plan for TB control in Australia beyond 2000.Australian Government Department of Health and Ageing; Canberra: 2002. Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-other-tb_plan.htm/$FILE/tbstrat_plan.pdf
Australian Bureau of Statistics. Australian Demographic Statistics, June 2013 Quarter. ABS Cat. No: 3101.0. Australian Bureau of Statistics. 2010.
World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th edn. Geneva: World Health Organization WHO/HTM/TB/2009.422.
Australian Government AusAID. Tackling tuberculosis in Western Province, Papua New Guinea: A long term approach to ensure effective and sustained TB services. [online]. Accessed on 29 July 2014. Available from: http://www.adi.org.au/wp-content/uploads/2013/07/2012_AusAID_TB-Strategy_Western-Province.pdf
Downloads
Published
How to Cite
License
Copyright (c) 2014 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
